Genetic Characterization of -acetyltransferase 2 Variants in Acquired Multidrug-resistant Tuberculosis in Indonesia
Overview
Pharmacology
Authors
Affiliations
Owing to the high resistance rate of tuberculosis (TB) to isoniazid, which is metabolized by -acetyltransferase 2 (NAT2), we investigated the associations between variants and multidrug-resistant (MDR)-TB. The acetylator status based on haplotypes of 128 patients with MDR-TB in Indonesia were compared with our published data from patients with anti-TB drug-induced liver injury (AT-DILI), TB and the general population. was more frequent in the MDR-TB group than in the AT-DILI group, TB controls and general controls. was significantly more frequent in patients with MDR-TB than in those with AT-DILI. and were detected at lower frequencies in patients with AT-DILI. Rapid acetylators were significantly more frequent in patients with MDR-TB than in those with AT-DILI. These results provide an initial data for optimizing TB treatment in the Indonesian population, and suggest that genotyping may help to select appropriate treatment by predicting TB-treatment effect.
Sanchez R, Acosta O, Laymito L, Oscanoa T, Guevara-Fujita M, Moscol S J Clin Tuberc Other Mycobact Dis. 2024; 37:100485.
PMID: 39502413 PMC: 11535994. DOI: 10.1016/j.jctube.2024.100485.
Soedarsono S, Mertaniasih N, Kusmiati T, Permatasari A, Ilahi W, Anggraeni A Antibiotics (Basel). 2023; 12(3).
PMID: 36978465 PMC: 10044547. DOI: 10.3390/antibiotics12030598.
Jayanti R, Long N, Phat N, Cho Y, Shin J Pharmaceutics. 2022; 14(5).
PMID: 35631576 PMC: 9147223. DOI: 10.3390/pharmaceutics14050990.
Fukunaga K, Kato K, Okusaka T, Saito T, Ikeda M, Yoshida T Front Genet. 2021; 12:652704.
PMID: 33815485 PMC: 8012690. DOI: 10.3389/fgene.2021.652704.